Filtered By:
Specialty: Cytology
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of date.

Order by Relevance | Date

Total 6 results found since Jan 2013.

Recycled Translation: Repurposing Drugs for Stroke
Transl Stroke Res. 2022 Feb 26. doi: 10.1007/s12975-022-01000-z. Online ahead of print.ABSTRACTStroke, which continues to be a leading cause of death and long-term disability worldwide, has often been described as a clinical graveyard. While multiple small molecule therapeutics have undergone clinical trials in stroke, currently only one Food and Drug Administration (FDA)-approved medication exists for the treatment of stroke, the biological, recombinant tissue plasminogen activator (rt-PA). Repurposing of therapeutics which have previously gained FDA approval for alternative indications serves as a prospective option for ...
Source: Cell Research - February 26, 2022 Category: Cytology Authors: Samantha E Spellicy David C Hess Source Type: research

Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood-Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss
Cell Mol Neurobiol. 2021 Jul 1. doi: 10.1007/s10571-021-01122-2. Online ahead of print.ABSTRACTThe only food and drug administration (FDA)-approved drug currently available for the treatment of acute ischemic stroke is tissue plasminogen activator (tPA), yet the therapeutic benefits of this drug are partially outweighed by the increased risk of hemorrhagic transformation (HT). Analysis of the NIH trial has shown that cigarette smoking protected tPA-treated patients from HT; however, the underlying mechanism is not clear. Nicotinic acetylcholine receptors (nAChR) has shown anti-inflammatory effect and modulation nAChR could...
Source: Cellular and Molecular Neurobiology - July 1, 2021 Category: Cytology Authors: Shuang Chen Yanyun Sun Fei Li Xinyu Zhang Xiaoyan Hu Xiaoyun Zhao Yixuan Li Hui Li Jianliang Zhang Wenlan Liu Guo-Qing Zheng Xinchun Jin Source Type: research

miR-9 Upregulation Integrates Post-ischemic Neuronal Survival and Regeneration In Vitro.
Abstract The irrefutable change in the expression of brain-enriched microRNAs (miRNAs) following ischemic stroke has promoted the development of radical miRNA-based therapeutics encompassing neuroprotection and neuronal restoration. Our previous report on the systems-level prediction of miR-9 in post-stroke-induced neurogenesis served as a premise to experimentally uncover the functional role of miR-9 in post-ischemic neuronal survival and regeneration. The oxygen-glucose deprivation (OGD) in SH-SY5Y cells significantly reduced miR-9 expression, while miR-9 mimic transfection enhanced post-ischemic neuronal cell v...
Source: Cellular and Molecular Neurobiology - December 11, 2018 Category: Cytology Authors: Nampoothiri SS, Rajanikant GK Tags: Cell Mol Neurobiol Source Type: research

Effects of Xiaoshuan Enteric-Coated Capsule on White and Gray Matter Injury Evaluated by Diffusion Tensor Imaging in Ischemic Stroke.
This study was to investigate the effects of XSECC on white and gray matter injury in a rat model of ischemic stroke by diffusion tensor imaging (DTI) and histopathological analyses. The ischemia was induced by middle cerebral artery occlusion (MCAO). The cerebral blood flow measured by arterial spin labeling was improved by treatment with XSECC on the 3rd, 7th, 14th and 30th days after MCAO. Spatiotemporal white and gray matter changes in MCAO rats were examined with DTI-derived parameters (fractional anisotropy, FA; apparent diffusion coefficient, ADC; axial diffusivity, λ//; radial diffusivity, λ⊥). The increased FA...
Source: Cell Transplantation - October 4, 2018 Category: Cytology Authors: Zhang J, Chen S, Shi W, Li M, Zhan Y, Yang L, Zou H, Lei J, Chai X, Gao K, Liu J, Wang W, Wang Y, Zhao H Tags: Cell Transplant Source Type: research